Tag: Lilly

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...

Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses ...

Amyotrophic lateral sclerosis has been a tough area for drug research, but Eli Lilly has been spreading its bets in ...

Indianapolis-based pharmaceutical behemoth Eli Lilly has filed lawsuits against four compounders claiming that they sold unapproved products that contain tirzepatide, ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the ...

Highly anticipated Phase 2 data for Amgen’s obesity drug show that on average, participants lost about 20% of their weight ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...